Statera Biopharma Inc Fka Cytocom Inc Quick Ratio (STAB) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Statera Biopharma Inc fka Cytocom Inc   (NASDAQ: STAB)

Statera Biopharma Inc Fka Cytocom Inc 's Quick Ratio

STAB's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 0.02 a new company low.

Within Major Pharmaceutical Preparations industry 620 other companies have achieved higher Quick Ratio than Statera Biopharma Inc Fka Cytocom Inc in third quarter 2022. While Quick Ratio total ranking in the third quarter 2022 has deteriorated compared to the prior quarter from 5554 to 5688.

Explain Quick Ratio?
How much Cash & cash equivalents STAB´s has?
What are STAB´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

STAB Quick Ratio (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3
Y / Y Current Liabilities Change 118.22 % 6443.18 % 2808.8 % 298.11 % 2035.37 %
Y / Y Cash & cash equivalent Change -94.64 % -94.8 % -97.74 % 115.43 % 2912.07 %
Quick Ratio MRQ 0.02 0.04 0.02 0.18 0.93
STAB's Total Ranking # 5688 # 5554 # 5415 # 4236 # 2491
Seq. Current Liabilities Change 13.02 % 30.5 % 34.04 % 10.39 % 3288.73 %
Seq. Cash & cash equivalent Change -29.4 % 116.85 % -83.3 % -79.05 % -31.41 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 621
Healthcare Sector # 1246
Overall Market # 5688


Quick Ratio Statistics
High Average Low
45.83 4.25 0.02
(Jun 30 2021)   (Mar 31 2022)




Financial Statements
Statera Biopharma Inc Fka Cytocom Inc 's Current Liabilities $ 22 Millions Visit STAB's Balance sheet
Statera Biopharma Inc Fka Cytocom Inc 's Cash & cash equivalent $ 1 Millions Visit STAB's Balance sheet
Source of STAB's Sales Visit STAB's Sales by Geography


Cumulative Statera Biopharma Inc Fka Cytocom Inc 's Quick Ratio

STAB's Quick Ratio for the trailling 12 Months

STAB Quick Ratio

 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 393.25 % 1263.33 % 698.89 % 330.04 % 257.36 %
Y / Y Cash & cash equivalent TTM Growth -90.89 % -57.9 % 30.14 % 520.57 % 447.75 %
Quick Ratio TTM 0.05 0.22 0.69 1.79 2.8
Total Ranking TTM # 4465 # 4690 # 4637 # 4187 # 4357
Seq. Current Liabilities TTM Growth 21.44 % 52.63 % 65.41 % 60.88 % 235.65 %
Seq. Cash & cash equivalent TTM Growth -71.68 % -51.14 % -35.89 % 2.74 % 30.83 %

Quick ratio ranking by company, industry and sector >> Back to STAB Financial Strength Comparisons >> Go to Compare STAB Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q3 2022 to $22.23 millions, cumulative Quick Ratio decreased to 0.05 below the Statera Biopharma Inc Fka Cytocom Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 579 other companies have achieved higher Quick Ratio than Statera Biopharma Inc Fka Cytocom Inc . While Quick Ratio overall ranking has improved so far to 4465, from total ranking during the twelve months ending second quarter 2022 at 4690.

Explain Quick Ratio?
How much Cash & cash equivalents STAB´s has?
What are STAB´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 580
Healthcare Sector # 1161
Within the Market # 4465


trailing twelve months Quick Ratio Statistics
High Average Low
20.97 3.36 0.05
(Jun 30 2021)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Neptune Wellness Solutions Inc   0.06 $ 1.412  Millions$ 23.529  Millions
Serina Therapeutics Inc   0.06 $ 0.466  Millions$ 8.149  Millions
Axim Biotechnologies Inc   0.05 $ 0.169  Millions$ 3.163  Millions
Scopus Biopharma Inc   0.05 $ 0.311  Millions$ 5.920  Millions
Inhibitor Therapeutics Inc   0.05 $ 0.053  Millions$ 1.088  Millions
Cnbx Pharmaceuticals Inc   0.05 $ 0.118  Millions$ 2.444  Millions
Aridis Pharmaceuticals Inc   0.04 $ 1.886  Millions$ 42.277  Millions
Skinvisible Inc   0.04 $ 0.127  Millions$ 2.968  Millions
Cytodyn inc   0.04 $ 4.676  Millions$ 122.319  Millions
Emmaus Life Sciences Inc   0.03 $ 1.179  Millions$ 41.523  Millions
Viveon Health Acquisition Corp   0.03 $ 0.286  Millions$ 10.607  Millions
Rebus Holdings Inc   0.02 $ 0.134  Millions$ 5.711  Millions
Statera Biopharma Inc fka Cytocom Inc   0.02 $ 0.506  Millions$ 22.231  Millions
Bespoke Extracts Inc  0.02 $ 0.011  Millions$ 0.519  Millions
Aeon Biopharma inc   0.02 $ 0.028  Millions$ 1.348  Millions
Cell Source Inc   0.02 $ 0.066  Millions$ 3.549  Millions
Q Biomed inc   0.02 $ 0.138  Millions$ 7.732  Millions
Oncotelic Therapeutics Inc   0.02 $ 0.254  Millions$ 16.211  Millions
Cen Biotech Inc  0.02 $ 0.148  Millions$ 9.828  Millions
Lifecore Biomedical Inc   0.01 $ 2.540  Millions$ 172.221  Millions
Intellipharmaceutics International Inc   0.01 $ 0.080  Millions$ 5.893  Millions
Novaccess Global Inc  0.01 $ 0.064  Millions$ 4.778  Millions
Actavia Life Sciences Inc   0.01 $ 0.039  Millions$ 3.012  Millions
Nanomix Corp  0.01 $ 0.050  Millions$ 3.897  Millions
Innovation1 Biotech Inc   0.01 $ 0.366  Millions$ 29.812  Millions
Bioadaptives Inc   0.01 $ 0.018  Millions$ 1.626  Millions
Provectus Biopharmaceuticals Inc   0.01 $ 0.067  Millions$ 8.824  Millions
Sangui Biotech International Inc  0.01 $ 0.007  Millions$ 0.911  Millions
Regen Biopharma Inc   0.01 $ 0.051  Millions$ 7.328  Millions
Propanc Biopharma Inc   0.01 $ 0.019  Millions$ 2.822  Millions

Date modified: 2026-06-22T14:32:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.